Tag: Ophthalmic emulsion

Following a May 2024 Class II voluntary recall of Klarity-C (cyclosporine 0.1%) ophthalmic emulsion, many patients were left wondering, 'Why is Klarity-C being discontinued?' The recall, initiated by manufacturer Imprimis NJOF, was a precautionary measure related to observed deviations in standard operating procedures.

While Ikervis and Verkazia both contain the same concentration of the active immunosuppressant ciclosporin, the key distinction lies in their approved indications, target patient populations, and dosing schedules. Both are ophthalmic emulsions, but the question, “What is the difference between ikervis and verkazia?” comes down to what specific inflammatory eye disease they are licensed to treat.